As markets reel under the Israel-Iran conflict, NVS, ENSG, MTZ, BILI and STRL stocks offer a safer path through volatility.

FORT WORTH, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or “the Company”) and Sports.com announced a sponsorship agreement with Racing Women LLC, the movement pioneering access and opportunity for women in motorsports and STEM programs worldwide.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=153249&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=153253&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153250&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=153286&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153254&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

COST's Q3 membership income rises 10% as executive signups, retention gains and a fee hike fuel recurring revenues.

Great Lakes Dredge & Dock (GLDD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Benitec Biopharma (BNTC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Mirion Technologies (MIR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sterling Infrastructure (STRL) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O'Heeron, will present a company update at the BIO International Convention 2025, June 16-19, 2025, in Boston, MA. The presentation will include recent corporate milestones and research advances using fibroblast-based technology for indications such as wound healing, multiple sclerosis, and psoriasis.

Alphabet Inc.'s Q1 FY2025 results crushed estimates, with EPS up nearly 49%, showcasing robust growth despite market fears of it being an "AI-disrupted" entity rather than an "AI enabler." Google Search remains resilient, with 10% YoY revenue growth and 1.5 billion monthly AI Overview users, challenging narratives of its decline against LLM competitors like ChatGPT. Google Cloud is a rapidly expanding profit engine, boasting 28% YoY revenue growth and a significant operating margin jump, solidifying its position as a key AI player.

Max Layton, Citi global head of commodities research, joins 'Squawk on the Street' to discuss the recent pullback in oil prices, the key factor to monitor and much more.

LOS ANGELES , June 16, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance" or "the Company") (NYSE: ELV) for violations of the federal securities laws. Shareholders who purchased the Company's securities between April 18, 2024 and October 16, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 11, 2025.

NEW YORK--(BUSINESS WIRE)--Total Wireless, a leading provider of premium, affordable and flexible wireless plans covered by the Verizon 5G network, today announces the launch of Total Spark, the latest social impact program from the Verizon Value portfolio. Designed to support working students, Total Spark is tailor-made to meet the Total Wireless community where they are - whether they're working full-time and going to school at night, balancing family obligations with school, part-time studen.

Aurora Cannabis is on track for its first profitable year, driven by a strategic pivot to high-margin medical cannabis and disciplined cost management. Strong international medical sales, improved margins, and debt elimination have led to consistent positive adjusted EBITDA and free cash flow. Aurora outperforms peers Tilray and Canopy Growth with better stock performance, lower dilution, and a clear path to profitability in FY2025.